Literature DB >> 11973156

How do extracellular pathogens cross the blood-brain barrier?

Xavier Nassif1, Sandrine Bourdoulous, Emmanuel Eugène, Pierre-Olivier Couraud.   

Abstract

Bacterial invasion of the meninges can occur as a consequence of bloodstream invasion by some bacterial pathogens. Bacteria enter the central nervous system following a direct interaction with the luminal side of the cerebral endothelium, which constitutes the blood-brain barrier. To breach the barriers protecting the brain, extracellular pathogens must cross a monolayer of tight junction-expressing endothelial or epithelial cells. The limited number of pathogens capable of crossing these tight barriers and invading the meninges suggests that they display very specific attributes. For Neisseria meningitidis, type IV pili have been identified as being essential for meningeal invasion and it is believed other, as-yet-unidentified factors are also involved.

Entities:  

Mesh:

Year:  2002        PMID: 11973156     DOI: 10.1016/s0966-842x(02)02349-1

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  47 in total

1.  Entry of Neisseria meningitidis into mammalian cells requires the Src family protein tyrosine kinases.

Authors:  Heiko Slanina; Alexandra König; Sabrina Hebling; Christof R Hauck; Matthias Frosch; Alexandra Schubert-Unkmeir
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

2.  Interaction of factor H-binding protein of Streptococcus suis with globotriaosylceramide promotes the development of meningitis.

Authors:  Decong Kong; Zhe Chen; Junping Wang; Qingyu Lv; Hua Jiang; Yuling Zheng; Maokai Xu; Xuyu Zhou; Huaijie Hao; Yongqiang Jiang
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

3.  Novel model to study virulence determinants of Escherichia coli K1.

Authors:  Naveed Ahmed Khan; Graham John Goldsworthy
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

Review 4.  Breaking the wall: targeting of the endothelium by pathogenic bacteria.

Authors:  Emmanuel Lemichez; Marc Lecuit; Xavier Nassif; Sandrine Bourdoulous
Journal:  Nat Rev Microbiol       Date:  2009-12-30       Impact factor: 60.633

5.  Microsatellite instability regulates transcription factor binding and gene expression.

Authors:  Patricia Martin; Katherine Makepeace; Stuart A Hill; Derek W Hood; E Richard Moxon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

Review 6.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1.

Authors:  Andrea Zelmer; Mark Bowen; Anne Jokilammi; Jukka Finne; J Paul Luzio; Peter W Taylor
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

8.  Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells.

Authors:  Hideyuki Takahashi; Russel W Carlson; Artur Muszynski; Biswa Choudhury; Kwang Sik Kim; David S Stephens; Haruo Watanabe
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

9.  Interaction of variable bacterial outer membrane lipoproteins with brain endothelium.

Authors:  Gaurav Gandhi; Diana Londoño; Christine R Whetstine; Nilay Sethi; Kwang S Kim; Wolfram R Zückert; Diego Cadavid
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

10.  Alternative Neisseria spp. type IV pilin glycosylation with a glyceramido acetamido trideoxyhexose residue.

Authors:  Julia Chamot-Rooke; Benoit Rousseau; Fanny Lanternier; Guillain Mikaty; Emilie Mairey; Christian Malosse; Guy Bouchoux; Vladimir Pelicic; Luc Camoin; Xavier Nassif; Guillaume Duménil
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.